A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache
Public ClinicalTrials.gov record NCT03107052. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Double-Dummy Study to Explore the Long-Term Safety and Efficacy of TEV-48125 for the Prevention of Cluster Headache
Study identification
- NCT ID
- NCT03107052
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 275 participants
Conditions and interventions
Conditions
Interventions
- Fremanezumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 26, 2017
- Primary completion
- Jun 10, 2019
- Completion
- Jun 10, 2019
- Last update posted
- Nov 8, 2021
2017 – 2019
United States locations
- U.S. sites
- 32
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 13834 | Phoenix | Arizona | 85018 | — |
| Teva Investigational Site 13819 | Canoga Park | California | 91303 | — |
| Teva Investigational Site 13811 | Santa Monica | California | 90404 | — |
| Teva Investigational Site 13823 | Stanford | California | 94305 | — |
| Teva Investigational Site 13837 | Aurora | Colorado | 80045 | — |
| Teva Investigational Site 13814 | Colorado Springs | Colorado | 80918 | — |
| Teva Investigational Site 13836 | Denver | Colorado | 80218 | — |
| Teva Investigational Site 13813 | Englewood | Colorado | 80113 | — |
| Teva Investigational Site 13821 | New Haven | Connecticut | 06510-2483 | — |
| Teva Investigational Site 13812 | Stamford | Connecticut | 06905 | — |
| Teva Investigational Site 13810 | Gainesville | Florida | 32607 | — |
| Teva Investigational Site 13815 | Orlando | Florida | 32806 | — |
| Teva Investigational Site 13829 | Ormond Beach | Florida | 32174 | — |
| Teva Investigational Site 13830 | St. Petersburg | Florida | 33709 | — |
| Teva Investigational Site 13842 | Tampa | Florida | 33612 | — |
| Teva Investigational Site 13840 | Tampa | Florida | 33634 | — |
| Teva Investigational Site 13833 | Columbus | Georgia | 31904 | — |
| Teva Investigational Site 13826 | Chicago | Illinois | 60614 | — |
| Teva Investigational Site 13818 | Ann Arbor | Michigan | 48104 | — |
| Teva Investigational Site 13835 | Las Vegas | Nevada | 89106 | — |
| Teva Investigational Site 13832 | Las Vegas | Nevada | 89113 | — |
| Teva Investigational Site 13831 | Lebanon | New Hampshire | 03756 | — |
| Teva Investigational Site 13820 | Princeton | New Jersey | 08540 | — |
| Teva Investigational Site 13827 | Albuquerque | New Mexico | 87102 | — |
| Teva Investigational Site 13816 | Amherst | New York | 14226 | — |
| Teva Investigational Site 13817 | New York | New York | 10019 | — |
| Teva Investigational Site 13809 | Raleigh | North Carolina | 27607 | — |
| Teva Investigational Site 13839 | Salisbury | North Carolina | 28144 | — |
| Teva Investigational Site 13825 | Cleveland | Ohio | 44195 | — |
| Teva Investigational Site 13824 | Philadelphia | Pennsylvania | 19107 | — |
| Teva Investigational Site 13841 | Richmond | Texas | 77307 | — |
| Teva Investigational Site 13822 | Virginia Beach | Virginia | 23454 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03107052, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2021 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03107052 live on ClinicalTrials.gov.